[{"data":1,"prerenderedAt":257},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care:0":3},{"blogPost":4,"otherBlogs":84},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":9,"modified_gmt":9,"slug":10,"status":11,"type":12,"link":13,"title":14,"content":16,"excerpt":19,"author":21,"featured_media":22,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":26,"categories":28,"tags":30,"class_list":31,"featured_media_src_url":39,"_links":40},721,"2026-09-25T17:34:12",{"rendered":8},"https://wp.ncikenya.go.ke/?p=721","2026-09-27T07:03:42","kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care","publish","post","https://wp.ncikenya.go.ke/2026/09/25/kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care/",{"rendered":15},"Kenya’s Efforts to Advance Cancer Prevention, Screening, Early Detection and Access to Care.",{"rendered":17,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>25\u003Csup>th\u003C/sup> September, 2026 – Hong Kong, China\u003C/strong> — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation, \u003Cstrong>“Kenya’s Efforts on Cancer Prevention, Screening, Early Detection and Access to Care,”\u003C/strong> highlighted the country’s efforts to build a coordinated and equitable national cancer-control system, while drawing lessons that may be relevant to other low- and middle-income countries.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg\" alt=\"\" class=\"wp-image-730\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522.jpg 960w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Emily Barsito Presenting on Kenya’s  Efforts on Cancer Prevention, Screening, Early Detection and Access to Care\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Cancer Prevention through Governance and Policy\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s response to the growing cancer burden is anchored in the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>, which established the National Cancer Institute of Kenya (NCI-K) to spearhead and coordinate cancer prevention and control nationally.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through NCI-K and a multisectoral approach, Kenya continues to strengthen leadership and coordination in cancer prevention and control, public information, education and awareness, and implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Investing in Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Prevention remains a key pillar of Kenya’s cancer-control efforts.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Public information, education and awareness initiatives are being used to increase knowledge about cancer risk factors, prevention and the importance of screening, while creating demand for early detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has also strengthened tobacco control as an important public-health intervention, including restrictions on smoking in public spaces to reduce population exposure to tobacco smoke.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>HPV Vaccination and Cervical Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya continues to advance efforts towards the elimination of cervical cancer through HPV vaccination.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">More than \u003Cstrong>four million girls aged 9–14 years\u003C/strong> have been vaccinated through school-based programmes and integration of HPV vaccination into primary healthcare.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This investment in prevention is critical to reducing the future burden of cervical cancer and protecting generations of Kenyan women.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Bringing Screening Closer to Communities\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has integrated cancer screening with \u003Cstrong>primary healthcare (PHC)\u003C/strong> to improve access to preventive and early-detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The country has also embraced innovative and culturally appropriate approaches to screening and awareness, including reaching underserved and hard-to-reach populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Integrating cancer prevention and screening into primary healthcare provides an opportunity to bring services closer to communities and strengthen early detection across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Early Detection and Diagnosis\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Early diagnosis remains essential to improving cancer outcomes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has invested in advanced oncology and diagnostic technologies, including \u003Cstrong>CT, MRI and PET-CT\u003C/strong>, to strengthen diagnosis, staging and treatment planning.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These investments support the country’s ambition to shift cancer diagnosis from predominantly \u003Cstrong>Stage III and IV disease towards Stage I and II\u003C/strong>, when treatment can be more effective and outcomes improved.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Decentralising Cancer Care\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Access to quality cancer care is being strengthened through the decentralisation of oncology services and the establishment of \u003Cstrong>regional cancer centres\u003C/strong> capable of providing comprehensive cancer treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This approach is helping reduce geographical disparities and bringing specialised cancer services closer to patients and their families.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sustainable health financing is equally important. Kenya’s \u003Cstrong>Universal Health Coverage (UHC)\u003C/strong> agenda and the \u003Cstrong>Social Health Insurance Fund (SHIF)\u003C/strong> oncology package are intended to reduce the financial burden associated with cancer treatment and protect families from catastrophic health expenditure.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Using Cancer Data to Guide Action\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable data is fundamental to effective cancer prevention and control.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s \u003Cstrong>National Cancer Registry\u003C/strong> provides critical information to support evidence-based policy, planning, resource allocation, research and evaluation of cancer-control interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Without reliable data, countries risk making decisions without a clear understanding of where the burden lies, who is affected and where resources are most needed.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Lessons for other Low- and Middle-Income Countries\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience offers several lessons that may be relevant to other countries facing similar challenges:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>1. Good governance is essential.\u003C/strong>\u003Cbr>Strong leadership, coordination and accountability provide the backbone for resilient cancer-control systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>2. Prevention is the best investment.\u003C/strong>\u003Cbr>Countries should prioritise preventing cancers wherever effective prevention interventions are available.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>3. Decentralise cancer care.\u003C/strong>\u003Cbr>Bringing services closer to communities can reduce geographical and socioeconomic inequalities in access to care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>4. Integrate cancer services with primary healthcare.\u003C/strong>\u003Cbr>Integration provides a practical pathway for expanding prevention, awareness and screening services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>5. Invest in sustainable health financing.\u003C/strong>\u003Cbr>Cancer care should be accessible to those who need it, not only to those who can afford it.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>6. Build reliable cancer information systems.\u003C/strong>\u003Cbr>Cancer data is the lifeblood of effective planning, resource allocation and programme evaluation. Without it, decision-making remains largely blind.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>7. Leverage innovation to advance equity.\u003C/strong>\u003Cbr>Technology and innovation should be deliberately deployed to expand access, improve quality and address the needs of underserved populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>A shared commitment to cancer control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience demonstrates that progress in cancer control requires more than investment in treatment alone. It requires \u003Cstrong>strong governance, prevention, early detection, accessible screening, reliable data, sustainable financing, innovation and equitable access to care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As countries work towards reducing the growing global cancer burden, sharing experiences and learning from one another can help accelerate progress—particularly in low- and middle-income settings.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya remains committed to strengthening its cancer-control systems and advancing equitable access to prevention, early detection and quality cancer care for all.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>#NCIK #HealthGovernance #CancerPreventionAndControlAct #PublicHealthPolicy #CancerControl #CancerPrevention #CancerScreening #EarlyDetection #UniversalHealthCoverage\u003C/strong>\u003C/p>\n",false,{"rendered":20,"protected":18},"\u003Cp>25th September, 2026 – Hong Kong, China — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care. The presentation, “Kenya’s Efforts on Cancer Prevention, Screening, […]\u003C/p>\n",1,734,"open","","standard",{"pagelayer_contact_templates":27,"_pagelayer_content":24,"footnotes":24},[],[29],4,[],[32,12,33,34,35,36,37,38],"post-721","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734523-768x1024.jpg",{"self":41,"collection":47,"about":50,"author":53,"replies":57,"version-history":60,"predecessor-version":63,"wp:featuredmedia":67,"wp:attachment":70,"wp:term":73,"curies":80},[42],{"href":43,"targetHints":44},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721",{"allow":45},[46],"GET",[48],{"href":49},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[51],{"href":52},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[54],{"embeddable":55,"href":56},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[58],{"embeddable":55,"href":59},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=721",[61],{"count":29,"href":62},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions",[64],{"id":65,"href":66},735,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions/735",[68],{"embeddable":55,"href":69},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/734",[71],{"href":72},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=721",[74,77],{"taxonomy":75,"embeddable":55,"href":76},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=721",{"taxonomy":78,"embeddable":55,"href":79},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=721",[81],{"name":82,"href":83,"templated":55},"wp","https://api.w.org/{rel}",[85,144,201],{"id":86,"date":87,"date_gmt":87,"guid":88,"modified":87,"modified_gmt":87,"slug":90,"status":11,"type":12,"link":91,"title":92,"content":94,"excerpt":96,"author":21,"featured_media":98,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":99,"categories":101,"tags":103,"class_list":104,"featured_media_src_url":107,"_links":108},669,"2026-05-29T07:10:19",{"rendered":89},"https://wp.ncikenya.go.ke/?p=669","kenya-advances-technology-driven-cancer-care","https://wp.ncikenya.go.ke/2026/05/29/kenya-advances-technology-driven-cancer-care/",{"rendered":93},"Kenya Advances Technology-Driven Cancer Care.",{"rendered":95,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), aimed at accelerating the transformation of Kenya’s cancer care system under the Universal Health Coverage agenda.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg\" alt=\"\" class=\"wp-image-671\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-300x200.jpeg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-768x512.jpeg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1.jpeg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Health CS, Hon. Aden Duale, leading the meeting\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions focused on the growing role of AI-enabled technologies, including systems already in use at Kenyatta National Hospital, in improving diagnostic precision, strengthening clinical decision-making, and enhancing efficiency in oncology care delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting also explored expansion of radiotherapy services, strengthening referral linkages between national and regional cancer centres, digital learning platforms for specialized oncology training, early cancer detection through community health systems, and improved access to essential oncology medicines.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement reaffirmed a shared commitment to practical, technology-driven solutions that improve access, quality, and equity in cancer care delivery across the country. The Cabinet Secretary was joined by Dr. Stephen Muleshe, Director of Public Health and Sanitation, Dr. Isaak Bashir, Director of Family Health, and other senior Ministry of Health officials.\u003C/p>\n",{"rendered":97,"protected":18},"\u003Cp>The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), […]\u003C/p>\n",672,{"pagelayer_contact_templates":100,"_pagelayer_content":24,"footnotes":24},[],[29,102],43,[],[105,12,33,34,35,36,37,38,106],"post-669","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066874129-1024x679.jpeg",{"self":109,"collection":114,"about":116,"author":118,"replies":120,"version-history":123,"predecessor-version":127,"wp:featuredmedia":131,"wp:attachment":134,"wp:term":137,"curies":142},[110],{"href":111,"targetHints":112},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669",{"allow":113},[46],[115],{"href":49},[117],{"href":52},[119],{"embeddable":55,"href":56},[121],{"embeddable":55,"href":122},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=669",[124],{"count":125,"href":126},2,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions",[128],{"id":129,"href":130},674,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions/674",[132],{"embeddable":55,"href":133},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/672",[135],{"href":136},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=669",[138,140],{"taxonomy":75,"embeddable":55,"href":139},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=669",{"taxonomy":78,"embeddable":55,"href":141},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=669",[143],{"name":82,"href":83,"templated":55},{"id":145,"date":146,"date_gmt":146,"guid":147,"modified":146,"modified_gmt":146,"slug":149,"status":11,"type":12,"link":150,"title":151,"content":153,"excerpt":155,"author":21,"featured_media":157,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":158,"categories":160,"tags":161,"class_list":162,"featured_media_src_url":165,"_links":166},694,"2026-07-09T13:26:16",{"rendered":148},"https://wp.ncikenya.go.ke/?p=694","parliamentary-health-committee-commends-nci-ks-progress-pledges-support-to-strengthen-cancer-control-in-kenya","https://wp.ncikenya.go.ke/2026/07/09/parliamentary-health-committee-commends-nci-ks-progress-pledges-support-to-strengthen-cancer-control-in-kenya/",{"rendered":152},"Parliamentary Health Committee Commends NCI-K’s Progress, Pledges Support to Strengthen Cancer Control in Kenya",{"rendered":154,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Nairobi, July 19, 2026\u003C/strong> – The National Assembly Departmental Committee on Health today paid a familiarization and oversight visit to the National Cancer Institute of Kenya (NCI-K) headquarters in Upper Hill, Nairobi, where Members of Parliament received a comprehensive briefing on the state of cancer in Kenya, the Institute’s achievements, and the implementation of the National Cancer Control Strategy 2023–2027.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee, led by its Chairperson, \u003Cstrong>Hon. Dr. James Nyikal\u003C/strong>, was received by the Chairperson of the NCI-K Board of Trustees, \u003Cstrong>Dr. Timothy Olweny\u003C/strong>, and the Chief Executive Officer, \u003Cstrong>Dr. Elias Melly\u003C/strong>, alongside members of the Institute’s management team.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the engagement, the Committee was taken through Kenya’s current cancer burden, highlighting the latest \u003Cstrong>GLOBOCAN 2024\u003C/strong> estimates, which indicate \u003Cstrong>35,865 new cancer cases\u003C/strong> and \u003Cstrong>22,888 cancer-related deaths\u003C/strong> annually. The discussion highlighted the growing need for sustained investments in cancer prevention, early detection, treatment, palliative care, research, and surveillance to address the increasing burden of the disease effectively.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee also received an overview of the Institute’s mandate, key milestones, and the progress made in implementing the \u003Cstrong>five strategic pillars of the National Cancer Control Strategy 2023–2027\u003C/strong>, which guide Kenya’s response to cancer through prevention, early detection, diagnosis and treatment, palliative care, governance, research, surveillance, and resource mobilization.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Presenting the Institute’s status, \u003Cstrong>Dr. Elias Melly\u003C/strong> acknowledged the significant progress made despite resource constraints. He noted that NCI-K has continued to coordinate national cancer control programmes, strengthen partnerships, enhance cancer awareness, support county governments, improve cancer surveillance systems, and advance research and policy development.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">However, the CEO emphasized that \u003Cstrong>insufficient funding remains the single greatest challenge\u003C/strong> affecting the full implementation of the National Cancer Control Strategy and the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">“While the Institute has achieved remarkable milestones with the limited resources available, adequate and sustainable funding is essential for us to fully implement our statutory mandate and deliver comprehensive cancer control interventions across the country,” Dr. Melly noted.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Members of the Committee commended the Institute for the notable achievements realized despite financial constraints, observing that the progress demonstrates prudent utilization of the resources allocated to NCI-K. They acknowledged the Institute’s growing impact in coordinating the national cancer control agenda and pledged to engage relevant government agencies to address the budgetary challenges affecting its operations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee further stressed the importance of strengthening cancer research as a key pillar in reducing the country’s cancer burden. \u003Cstrong>Hon. Dr. Robert Pukose\u003C/strong>, Member of Parliament for Endebess Constituency, emphasized that increased investment in research is critical to generating evidence that informs cancer prevention, early detection, diagnosis, treatment, and policy decisions. He called for enhanced funding to enable the Institute to establish and sustain robust cancer research programmes, a position that received unanimous support from the Committee members.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting also explored the management of Regional Cancer Centres across the country. \u003Cstrong>Hon. Pauline Lenguris\u003C/strong>, Woman Representative for Samburu County, raised the need to strengthen the governance and coordination of these centres and proposed that their management be placed under the National Cancer Institute of Kenya to promote uniform standards, enhance coordination, and improve service delivery nationwide. The Committee noted the proposal for further consideration as part of ongoing discussions on strengthening cancer care systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">In his remarks, \u003Cstrong>Dr. Timothy Olweny\u003C/strong>, Chairperson of the NCI-K Board of Trustees, thanked the Parliamentary Health Committee for its continued support and oversight, noting that Parliament plays a critical role in creating an enabling environment for effective cancer control through legislation, policy support, and adequate resource allocation.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visit reaffirmed the shared commitment between Parliament and the National Cancer Institute of Kenya to strengthen the country’s cancer response through increased investment, strategic partnerships, research, and sustainable financing. The Institute remains committed to working closely with Parliament, the Ministry of Health, county governments, development partners, and other stakeholders to accelerate the implementation of the National Cancer Control Strategy and improve cancer outcomes for all Kenyans.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":156,"protected":18},"\u003Cp>Nairobi, July 19, 2026 – The National Assembly Departmental Committee on Health today paid a familiarization and oversight visit to the National Cancer Institute of Kenya (NCI-K) headquarters in Upper Hill, Nairobi, where Members of Parliament received a comprehensive briefing on the state of cancer in Kenya, the Institute’s achievements, and the implementation of the […]\u003C/p>\n",695,{"pagelayer_contact_templates":159,"_pagelayer_content":24,"footnotes":24},[],[21],[],[163,12,33,34,35,36,37,164],"post-694","category-uncategorized","https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/DSC_2379-1024x683.jpg",{"self":167,"collection":172,"about":174,"author":176,"replies":178,"version-history":181,"predecessor-version":184,"wp:featuredmedia":188,"wp:attachment":191,"wp:term":194,"curies":199},[168],{"href":169,"targetHints":170},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694",{"allow":171},[46],[173],{"href":49},[175],{"href":52},[177],{"embeddable":55,"href":56},[179],{"embeddable":55,"href":180},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=694",[182],{"count":21,"href":183},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694/revisions",[185],{"id":186,"href":187},696,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694/revisions/696",[189],{"embeddable":55,"href":190},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/695",[192],{"href":193},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=694",[195,197],{"taxonomy":75,"embeddable":55,"href":196},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=694",{"taxonomy":78,"embeddable":55,"href":198},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=694",[200],{"name":82,"href":83,"templated":55},{"id":202,"date":203,"date_gmt":203,"guid":204,"modified":203,"modified_gmt":203,"slug":206,"status":11,"type":12,"link":207,"title":208,"content":210,"excerpt":212,"author":21,"featured_media":214,"comment_status":23,"ping_status":23,"sticky":18,"template":24,"format":25,"meta":215,"categories":217,"tags":218,"class_list":219,"featured_media_src_url":221,"_links":222},704,"2026-09-01T09:58:04",{"rendered":205},"https://wp.ncikenya.go.ke/?p=704","kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership","https://wp.ncikenya.go.ke/2026/09/01/kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership/",{"rendered":209},"Kenya Announces Major Reduction in Cancer Treatment Costs Through Pfizer Partnership",{"rendered":211,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating several cancers by more than seven times, with the cost of some medicines expected to fall from as much as KSh. 1 million to below KSh. 50,000 per treatment cycle.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The development follows discussions between President William Ruto and Pfizer Chairman and Chief Executive Officer Albert Bourla during their meeting at State House, Nairobi.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement covers medicines used in the treatment of breast, stomach, colorectal, lung, prostate and oesophageal cancers, as well as leukaemia, lymphoma and multiple myeloma.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>“Today, Kenya has made a breakthrough in the treatment of several cancers,” President Ruto said.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The arrangement brings together Pfizer and the Kenya Medical Supplies Authority (KEMSA) under Pfizer’s \u003Cem>Accord for a Healthier World\u003C/em>, a global initiative through which the company provides medicines to lower-income countries on a not-for-profit basis. Kenya joined the Accord in June 2025.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The significant reduction in medicine costs is expected to improve access to cancer treatment and ease the financial burden faced by patients and their families. According to the President, the lower prices will enable the Social Health Authority (SHA) KSh. 800,000 cancer package to fully cover treatment, substantially reducing the need for additional out-of-pocket payments.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement will also provide Kenya with access to newer cancer therapies, helping address delays that patients have historically experienced in accessing innovative and potentially life-saving treatments.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>In addition, Pfizer is expected to make relevant technologies and newer medicines available to support local pharmaceutical manufacturing in Africa, contributing to efforts to strengthen the continent’s capacity to produce essential medical commodities.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>This development comes at a critical time as cancer continues to pose a major public health challenge in Kenya. The high cost of diagnosis and treatment has for years placed a significant financial burden on patients and families, with some patients unable to complete their prescribed treatment.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) welcomes this landmark development as an important step towards advancing equitable access to quality, affordable and timely cancer care. The partnership reinforces Kenya’s commitment to reducing the financial barriers to cancer treatment and strengthening the country’s broader cancer control efforts.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Towards a Cancer-Free Nation.\u003C/strong>\u003C/p>\n",{"rendered":213,"protected":18},"\u003Cp>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines. The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating […]\u003C/p>\n",705,{"pagelayer_contact_templates":216,"_pagelayer_content":24,"footnotes":24},[],[21],[],[220,12,33,34,35,36,37,164],"post-704","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/5807a4d5-f491-4f23-9e6d-150ccd688d09_HREKm0GXkAElEp1-og_image.webp",{"self":223,"collection":228,"about":230,"author":232,"replies":234,"version-history":237,"predecessor-version":240,"wp:featuredmedia":244,"wp:attachment":247,"wp:term":250,"curies":255},[224],{"href":225,"targetHints":226},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704",{"allow":227},[46],[229],{"href":49},[231],{"href":52},[233],{"embeddable":55,"href":56},[235],{"embeddable":55,"href":236},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=704",[238],{"count":21,"href":239},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704/revisions",[241],{"id":242,"href":243},706,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704/revisions/706",[245],{"embeddable":55,"href":246},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/705",[248],{"href":249},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=704",[251,253],{"taxonomy":75,"embeddable":55,"href":252},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=704",{"taxonomy":78,"embeddable":55,"href":254},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=704",[256],{"name":82,"href":83,"templated":55},1792071274344]